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Abstract— Graphs can be used to effectively represent 
complex data structures.  Learning these irregular data in 
graphs is challenging and still suffers from shallow learning. 
Applying deep learning on graphs has recently showed good 
performance in many applications in social analysis, 
bioinformatics etc. A message passing graph convolution 
network is such a powerful method which has expressive power 
to learn graph structures. Meanwhile, circRNA is a type of non-
coding RNA which plays a critical role in human diseases. 
Identifying the associations between circRNAs and diseases is 
important to diagnosis and treatment of complex diseases. 
However, there are limited number of known associations 
between them and conducting biological experiments to identify 
new associations is time consuming and expensive. As a result, 
there is a need of building efficient and feasible computation 
methods to predict potential circRNA-disease associations. In 
this paper, we propose a novel graph convolution network 
framework to learn features from a graph built with multi-
source similarity information to predict circRNA-disease 
associations. First we use multi-source information of circRNA 
similarity, disease and circRNA Gaussian Interaction Profile 
(GIP) kernel similarity to extract the features using first graph 
convolution. Then we predict disease associations for each 
circRNA with second graph convolution. Proposed framework 
with five-fold cross validation on various experiments shows 
promising results in predicting circRNA-disease association and 
outperforms other existing methods. 
Keywords—graph convolution network, circRNA-disease 
associations, deep learning, message passing 
I. INTRODUCTION 
Non-Euclidian structure of graphs has the capability to 
express complex data representations in more meaningful 
ways. But learning problems on graphs are challenging due to 
the complex and irregular nature of the underlying patterns of 
these data. One approach is to convert the graph into lower 
dimensional space and use traditional learning methods on the 
reduced space. This process can be affected by loss of some 
graph properties and suffer from shallow learning. On the 
other hand, deep learning has good performance in many 
applications such as convolution neural networks which can 
extract complex and high-level features in data like images. 
As a result, more researchers are working on studies to 
integrate deep learning into graph problems. Graph 
Convolution Neural Network [1, 2] is such a powerful tool 
which is able to learn graph data with irregularities using 
various types of convolutional operators. Message passing 
convolution is one type of convolution method which 
aggregates neighbor nodes information to learn global 
structure of the graph eventually.  
RNA-Disease network with complex relations is a good 
candidate for a graph data representation and can be used to 
predict RNA-disease associations. This is because of the fact 
that non-coding RNAs that form the majority of human 
genome transcripts involve in a wide range of biological 
processes and evidence proves that they are correlated with 
many complex human diseases. As a result, there is an 
increasing interest to develop many computational methods to 
discover the potential associations between diseases and 
RNAs. Using these computational methods, we can enhance 
biomarker discovery for various diseases and limit the 
expensive wet lab experiments only to verify predicted 
associations using computational methods. 
There are three types of non-coding RNAs: small non-
coding microRNAs(miRNAs), long non-coding 
RNAs(lncRNAs) and circular RNA (circRNA). Most of the 
existing research has focused on miRNA and lncRNA and 
they can be broadly divided into two categories: known 
ncRNA-disease association based and machine learning based 
approaches. The first category of methods is using known 
ncRNA-disease associations to forecast potential associations. 
It assumes that similar RNAs or diseases have similar 
connection patterns. As an example, if disease 1 and RNA 1 
are associated and disease 2 and disease 1 are very similar, it 
is obvious that RNA 1 and disease 2 are also related. Due to 
the lack of existing known associations, some prediction 
methods tend to use biological information related to RNAs 
such as genome location and tissue specificity [3-7]. As an 
example, the RNAs close to each other in the genome are 
frequently associated with the same disease. However, these 
prediction methods need to collect more data to correctly find 
the similarity. So, this is not applicable to diseases and RNAs 
in which tissue specific gene records are not available. Also, 
the performance of the methods leverages on the correctness 
of the similarity definitions. Another type of method in this 
category is to build a bio network fusing disease similarity and 
RNA similarity sub networks and use methods like random 
walk [8-11]. In addition to the challenges mentioned above, 
some information can be lost while fusing these sub networks. 
The second category of methods utilizes machine learning 
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algorithms to learn the association between RNAs and 
diseases. Many machine learning algorithms such as naïve 
base classifier and support vector machine have been applied 
in this area. However, these methods use only a part of RNA 
and disease information and do not fuse them completely and 
the performance can be affected because of the unbalance 
distribution of data. Anyway, above methods fail to apply to a 
new disease without any related RNA. Matrix factorization 
(MF) [12-15] is one of the most popular machine learning 
based methods. Traditional matrix factorization methods learn 
only linear features between RNAs and diseases. But real 
associations between RNAs and diseases are too complicated 
and MF cannot capture such associations and they do not get 
the use of integrating biological information from different 
cores. 
circRNA is a new type of endogenous non-coding RNA 
molecules which has been discovered in recent years [16,17] 
and can be stably present in various types of cells. Therefore, 
recent studies have shown that circRNA plays a critical role in 
human diseases and circRNA is a good biomarker for disease 
diagnosis and treatments. With the increment of 
experimentally verified circRNA-disease associations, 
computational models can be built to find new potential 
circRNA-disease associations. MRLDC [18] is one of the few 
existing computational frameworks which recognize 
circRNA-disease associations assuming that similar 
functioning circRNAs are associated with similar diseases. 
Yan et al. [19] introduced DWNN-RLS to identify circRNA-
disease associations using Regularized Least Squares. 
KATZHCDA [20], PWCDA and RWRHCD [21] are other 
methods proposed using a heterogeneous network built with 
disease phenotype similarity and circRNA expression 
profiles. Due to the limited number of verified circRNA-
disease associations and noise in shallow learning, above 
models suffer from many false negatives. 
However, all the previously mentioned methods are 
shallow learning methods and cannot extract deep and 
complex representations of RNA disease associations. Deep 
learning methods can make better performance in extracting 
non-linear and complex feature representations. To overcome 
the limitations, hybrid computational models with deep 
learning techniques have been developed to extract non-linear 
features of RNA and diseases [22-25]. As an example, 
combined model with Convolutional Neural Network (CNN) 
is able to detect high level features from the input data and 
also the noise can be filtered out during the feature extraction 
process of CNN [26-28]. However, most of the previous 
computational methods failed to deeply integrate topological 
information of heterogeneous networks made of RNAs and 
diseases. Meanwhile, graph learning further can capture both 
global and local representation of features relevant to diseases 
and RNAs and more interestingly deep graphs open up the 
ability to apply deep learning operations in the domain of 
irregular, varying graph data. As a result, there is an increased 
attention on using deep graph learning to predict the RNA-
disease associations as graph convolutional networks are 
proven to be an effective and efficient model for information 
propagation in networks. GCNCDA [29] is a work which 
utilizes graph convolution to predict circRNA-disease 
associations. They employ FastGCN to extract features of 
circRNA-disease associations and final predictions are based 
on another classifier Forest PA. Other works [30] and [31] use 
spectral based graph convolutions to predict lncRNA-disease 
and miRNA-disease associations respectively. Both of the 
above models use spectral based convolutions which makes 
eigenfunctions of Laplacian matrix different from one graph 
to another. Also, all the computations of Laplacian matrix 
need to be processed in one time which makes computational 
complexity high for large graphs. On the other hand, the 
FastGCN algorithm assumes that nodes in the graph are 
identically distributed which prevents capturing the actual 
graph structure. 
In this paper, we propose a spatial based two layer graph 
convolution network to predict circRNA-disease associations 
and its main contributions are summarized below. 
• First, integrate multi-source information such as 
circRNA sequence similarity, disease and circRNA 
GIP similarity to build a circRNA-disease network. 
• Then, first convolution layer learns feature 
representations of each node adhering topological 
structure of the built circRNA-disease network. 
• Next, second convolution layer predicts the 
associativity of multiple diseases of each circRNA 
using learnt latent feature vectors. 
Thus, the proposed model overcomes the limitations of 
shallow learning and spectral convolution, and relies on deep 
graph convolutions for both extracting meaningful features 
and predicting the associations. Message passing convolution 
is used to aggregate neighborhood information and eventually 
to learn the real global graph structure. The results of 
extensive experiments show that the proposed model can 
successfully predict new circRNA-disease associations and 
has comparative performance compared to other models. 
II. METHOD OVERVIEW 
This section describes the proposed method with the 
detailed information regarding different similarity value 
calculations, known cicRNA-disease association data, 
building circRNA-disease network and message passing 
convolution. Mainly the process can be divided into four 
steps: calculation and integration of multiple sources of 
similarity information, building a circRNA-disease network, 
apply first layer graph convolution to extract high level 
features of the network and predicting the circRNA-disease 
associations with the second layer of graph convolution. Fig. 
1 depicts the overview of the method. 
A. circRNA-disease Associations 
Experimentally verified known circRNA-disease 
association data are extracted from circR2Disease [32]. There 
were about 900 circRNA-disease associations verified with 
evidence. All of these associations are in between more than 
700 circRNAs and more than 100 diseases. The adjacency 
matrix of circRNA-disease association is denoted by 𝐴𝑆. If 
𝐴𝑆(𝑖, 𝑗)  is equal to 1 there is an association between 
circRNA 𝑖  and disease 𝑗. Otherwise 𝐴𝑆(𝑖, 𝑗) is equal to 0. 
 
B. Multi-source Similarity Features 
 
1) circRNA Sequence Similarity 
 
circRNA related RNA based sequence data are taken from 
circBase database[33]. Then Needleman-Wunsch method, a 
base pairing algorithm is used to calculate circRNA sequence  
Fig. 1. Overview of the method: 1. Multiple feature similarity calculation and integration, 2 Building circRNA-disease network, 3. Extracting features with 
first graph convolution, 4. Predict disease associations for each circRNA with second graph convolution.
 
similarity. 𝐶𝑆(𝑖, 𝑗)  represents the similarity value between 
the circRNA 𝐶𝑖  and 𝐶𝑗 . Each similarity value 𝐶𝑆(𝑖, 𝑗)  is 
normalized using (1) where 𝑁𝑊(𝑖, 𝑗)  is the Needleman-
Wunsch algorithm score between circRNA 𝑖 and 𝑗.  
 
𝐶𝑆(𝑖, 𝑗) =  
𝑁𝑊(𝑖,𝑗)
√𝑁𝑊(𝑖,𝑖)√𝑁𝑊(𝑗,𝑗)
              (1) 
 
2) circRNA GIP Kernel Similarity 
 
If two circRNAs are more similar, then they are likely to 
be associated with the same set of diseases. Based on the 
above assumption, known circRNA-disease associations are 
used to calculate circRNA GIP kernel similarity. This 
similarity score between circRNA 𝐶𝑖  and 𝐶𝑗  is denoted as 
𝐶𝐺(𝑖, 𝑗)  and calculated using matrix 𝐴𝑆 as mentioned below 
in (2).  
 
𝐶𝐺(𝑖, 𝑗) = 𝑒𝑥𝑝 (−𝛼𝑐  ‖𝑃𝐶𝑖 −  𝑃𝐶𝑗‖
2
) (2) 
 
Here, 𝑃𝐶𝑖  means the interaction profile of circRNA 𝐶𝑖 with 
each disease which is the 𝑖 th row of matrix 𝐴𝑆 . 𝛼𝑐  is an 
adjusting parameter which controls the range of values and  
𝑁𝑐 is the total number of circRNAs. 
𝛼𝑐 = 𝛼?̂? [
1
𝑁𝑐
∑ ‖ 𝑃𝐶(𝑖)‖
𝑁𝑐
𝑖=1 ]⁄           (3) 
 
3) Disease GIP Kernel Similarity 
 
GIP kernel similarity algorithm is used to calculate 
𝐷𝐺(𝑖, 𝑗)  which is the disease GIP kernel similarity between 
𝐷𝑖 and 𝐷𝑗. The process is similar to calculating circRNA GIP 
kernel similarity and given in (4).  
𝐷𝐺(𝑖, 𝑗) = exp (−𝛼𝐷  ‖𝑃𝐷𝑖 − 𝑃𝐷𝑗‖
2
) (4) 
𝑃𝐷𝑖  is the interaction profile of disease 𝐷𝑖  and also the 𝑖 th 
column vector of matrix 𝐴𝑆 . 𝛼𝐷  is the range adjusting 
parameter and 𝑁𝐷 is the total number of diseases. 
𝛼𝐷 = 𝛼?̂?/ [
1
𝑁𝐷
∑ ‖ 𝑃𝐷(𝑖)‖
𝑁𝐷
𝑖=1 ]  (5) 
 
C. Message Passing Graph Convolution 
circRNA-disease network is constructed using calculated 
similarity features mentioned in above sections. This network 
is a graph 𝐺 =  (𝑉, 𝐸)  where 𝑉 =  𝑣1, … , 𝑣𝑛  which has 𝑛 
number of nodes and  𝐸 contains 𝑚 number of edges between 
nodes considering the calculated similarity feature values. 
The structural information of this graph can be denoted using 
an adjacency matrix A. Given a graph 𝐺, with initial features 
𝑋𝑛×𝑑 where 𝑑 is starting dimension of each node 𝑛, our goal 
is to map nodes to a lower dimensional feature matrix 𝑍𝑛×𝑎 
by learning the topological information of the graph, 
where  𝑎 is less than 𝑑.  Message passing convolution 
operation is used for this purpose and it can be 
mathematically defined as in (6).  
 
ℎ𝑣
𝑘 = 𝑓(𝑊𝑘 ∑ ℎ𝑢
𝑘−1
𝑢∈𝑁(𝑣),𝐴 )       (6) 
 
Let ℎ𝑣
𝑘 be the output of the 𝑘𝑡ℎ convolutional layer and input 
is ℎ𝑢
𝑘−1where 𝑢 denotes the neighbors of node 𝑣. Usually, we 
can start with one-hot feature vectors and use graph structure 
which consists of different similarities to extract high level 
features of each node and do the classification based on the 
calculated features. 𝑊𝑘 is the learnable parameters of the 𝑘
𝑡ℎ 
layer and 𝑓 is the activation function such as ReLU.  
 
Based on the above facts, we utilize message passing 
convolution to aggregate different features of neighbors, and 
eventually learn graph structure to extract high level features 
of circRNA-disease associations and predict new 
associations using them. As an example in Fig. 1, node 𝐶1 
starts with one hot vector and learn the edges with  𝐶2, 𝐶3, 𝐶5, 
𝑑1 and update features of 𝐶1 accordingly. This is because we 
know that 𝐶1 is more similar with circRNAs 𝐶2, 𝐶3, 𝐶5 and 
also it is associated with 𝑑1  disease based on known 
associations. Next, first convolution layer converts learned 
features to lower dimensional high level feature embedding 
of each node where the second layer gets the output feature 
embedding of previous layer to do the final predictions. We 
use already known associations as the output labels to 
calculate the loss and back propagation to learn the model 
parameters.   
 
III. EXPERIMENTS AND RESULTS 
 
We did various experiments on the dataset circR2Disease 
to evaluate the performance of the graph convolution 
algorithm in predicting circRNA-disease association. We 
used five-fold cross validation as it has more reliability in the 
performance and also avoid overfitting issues. So we divide 
data into five subsets where each set is taken to test the 
performance while others are used for training. Thus, we can 
repeat the process five times and get the average as the model 
performance. At first, training and testing performance of the 
model is analyzed and then we did experiments with different 
number of disease predictions varying from 3 to 50. In the 
next experiment we show the model performance for each 
individual disease. Here we selected five diseases having 
frequent associations with the circRNAs in the dataset to 
evaluate the model. Hyper-parameter optimization test and 
comparison with other existing methods are presented in the 
next section. Finally, we did a case study to further 
demonstrate the capability of the model on predicting new 
circRNA-disease association based on the existing 
associations. Evaluation metrices include accuracy, 
precision, recall, f1 score which are defined below. 
 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =  
𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁
 
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =  
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
 
𝑅𝑒𝑐𝑎𝑙𝑙 =  
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
 
𝐹1 𝑠𝑐𝑜𝑟𝑒 =  
2 𝑇𝑃
2 𝑇𝑃 + 𝐹𝑃 + 𝐹𝑁
 
 
Where 𝑇𝑃, 𝑇𝑁, 𝐹𝑃, 𝐹𝑁 are true positives, true negatives, 
false positives and false negatives, respectively. Further we 
use AUC measure to evaluate the model and compare the 
performance with others. 
 
 
 
A. Training and Testing Performance 
 
In this experiment we observed model performance in the 
learning process. Fig. 2(a) depicts the training error against 
the epoch for different number of disease prediction while 
Fig. 2(b) plotted both training and testing error on 50 disease 
predictions with the epoch number. We can observe that 
training errors of all three models are gradually decreasing as 
the number of epochs increase. Though 3 disease 
classification has the highest reduction of training error in 
early epochs due to its simplicity, all learning curves 
converge to same error with fewer number of epochs like 20. 
On 50 disease prediction, both training and testing error 
converge within 10 epochs and we can observe proposed 
model has a good learning behavior. 
 
B. Different Number of Disease Predictions 
 
To evaluate the impact of the increase of number of 
disease predictions, different models are trained for 3 disease, 
10 disease and 50 disease predictions. The performance of 
each model is measured using 5-fold cross validation and the 
results are summarized in Tables I, II and III.  
In all three different models, average accuracy is more 
than 96% with very small standard deviation and 98% with 
three disease prediction. Also, the precision value in most of 
the test cases and the average precision is very high which 
denotes that false positives are very less with the graph 
convolution model in predicting the associativities. Recall 
values are having lowest performance like 89% score in some 
test folds and the lowest average is 92% with 50 disease 
prediction. However, f1 score is a reliable measure which 
encounters both precision and recall and has stable 
performance about 95% with the highest standard deviation 
0.02. Further capability of the model in predictions can be 
observed with almost similar AUC 96%.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    (a)Training error for different number of diseases.                                   (b)Training and testing error for 50 diseases. 
 
Fig. 2. Performance of the model in the training process 
 
 
 
 
 
  
 
TABLE I.  RESULTS OF 5-FOLD CV ON THREE DISEASES PREDICTION 
Test fold Accuracy Precision Recall F1-score AUC 
1 0.9877 1.0000 0.9091 0.9524 0.9545 
2 0.9939 1.0000 0.9722 0.9859 0.9861 
3 1.0000 1.0000 1.0000 1.0000 1.0000 
4 0.9877 0.9444 0.9189 0.9315 0.9572 
5 0.9753 0.9048 0.9744 0.9383 0.9827 
Average 0.9889 ± 0.008 0.9698 ± 0.039 0.9549 ± 0.035 0.9616 ± 0.027 0.9761 ± 0.018 
 
TABLE II.  RESULTS OF 5-FOLD CV ON TEN DISEASES PREDICTION 
Test fold Accuracy Precision Recall F1-score AUC 
1 0.9877 1.0000 0.8955 0.9449 0.9478 
2 0.9816 1.0000 0.9394 0.9688 0.9697 
3 0.9938 1.0000 0.9870 0.9935 0.9935 
4 0.9877 0.9726 0.9467 0.9595 0.9727 
5 0.9444 0.9487 0.9250 0.9367 0.9612 
Average 0.9791 ± 0.018 0.9843 ± 0.021 0.9387 ± 0.030 0.9607 ± 0.020 0.9690 ± 0.015 
 
TABLE III.  RESULTS OF 5-FOLD CV ON FIFTY DISEASES PREDICTION 
Test fold Accuracy Precision Recall F1-score AUC 
1 0.9571 1.0000 0.8851 0.9391 0.9426 
2 0.9571 0.9929 0.9329 0.9619 0.9664 
3 0.9753 1.0000 0.9650 0.9822 0.9825 
4 0.9630 0.9790 0.9396 0.9589 0.9696 
5 0.9506 1.0000 0.8929 0.9434 0.9464 
Average 0.9606 ± 0.008 0.9944 ± 0.008 0.9231 ± 0.030 0.9571 ± 0.015 0.9615 ± 0.015 
        Average performance of each metric of above 3 different 
models is shown in Fig. 3. When the number of disease 
predictions increased we see slight drop of accuracies but still 
greater than 95%. Compared to the precision, recall values 
are little bit lower with all three models while average values 
of them are greater than 90%. Meanwhile, both f1 score and 
AUC show stable performance of the model without 
depending on the number of diseases. Overall, model 
performs well with all measures above 90%. 
 
 
Fig. 3. Comparison of average 5-fold CV results of three, ten and fifty disease 
predictions 
 
C. Comparison of Different Disease Prediction 
Performance 
 
Here we use 50 disease prediction model to compare the 
performance of individual disease on the test dataset. 5-fold 
cross validation is utilized with the model and the average  
performance of each disease is given in Table IV. For the 
comparison, these values are plotted in a bar chart and shown 
in Fig. 4.   
 
 
Fig. 4. Comparison of average 5-fold CV results of five individual disease 
prediction 
 
We see high average accuracy and precision values for all 
five disease predictions which indicates the effectiveness of 
the model and low false positives. Both f1 score and AUC are 
having similar performance except Colorectal Cancer which 
further proves the robustness of the model. Only Glioma and 
Colorectal Cancer have lower recall and f1 score with 
compared to other diseases. But we can conclude that at least 
three diseases out of five have very high performance while 
all the measures are greater than or equal to 90% relevant to 
all diseases. 
D. Comparison with other Methods and Parameter 
Optimization 
 
TABLE IV.  RESULTS OF 5-FOLD CV ON INDIVIDUAL 5 DISEASES 
Disease Accuracy Precision Recall F1 AUC 
Stomach Cancer 0.9571 1.0000 0.8851 0.9391 0.9426 
Breast Cancer 0.9571 0.9929 0.9329 0.9619 0.9664 
Colorectal Cancer 0.9753 1.0000 0.9650 0.9822 0.9825 
Esophageal Cancer 0.9630 0.9790 0.9396 0.9589 0.9696 
Glioma 0.9506 1.0000 0.8929 0.9434 0.9464 
 
TABLE V.  COMPARISON WITH OTHERS USING 5-FOLD CV GENERATED  AUC
  
 Our model GCNCDA DWNN-RLS KATZHCDA PWCDA  RWRHCD 
AUC 0.9615 0.9090 0.8854 0.7936 0.8900 0.6660 
 
Few studies have introduced models with different 
methods to predict circRNA-disease associations. To 
compare our model with them, we use 5-fold cv average AUC 
values on 50 disease prediction model and results are given 
in Table V. 
 
Based on the results, we can observe that the proposed 
model effectively predicts potential circRNA related diseases 
with average 96% AUC. Next, we did hyper-parameter 
optimization test for the threshold value 𝛾 which is used to 
determine the connectivity of two nodes based on the 
integrated similarity values. If the calculated similarity 
between nodes 𝑖 and 𝑗 is greater than 𝛾, an edge is built  
between nodes 𝑖 and 𝑗. We used different 𝛾 values and the 
average accuracy and f1 score are recorded in the Table VI. 
TABLE VI.  COMPARISON OF THE MODEL WITH DIFFERENT γ VALUES 
γ 0.01 0.1 0.2 0.5 0.8 0.9 
Accuracy 0.8997 0.9059 0.9359 0.9653 0.9506 0.9444 
F1 score 0.8636 0.8857 0.8957 0.9655 0.9306 0.9090 
 
Above results show that both accuracy and f1 score are 
having values less than or equal to 90% for 𝛾 values less than 
0.1. When we increase 𝛾 from 0.1 to 0.5 there is an increment 
for both values and reaches the highest with 0.5. Again we  
 
 
 
see a slight drop of accuracy with 0.8 and 0.9. This means too 
sparse or too dense graphs can degrade the performance of 
convolution model. Right connectivities with appropriate 
threshold makes learning better in both feature extraction and 
prediction. So we selected 𝛾 as 0.5 in our experiments.  
 
E. Case Study 
The purpose of this study is to evaluate the capabilities of 
the model for identifying new circRNA-disease associations 
based on the existing associations on the training data. Here 
we select Stomach Cancer for this case study where we 
calculate prediction probabilities of each association with this 
disease and sort them in the descending order. Next, we rank 
each association and top 20 predictions are given in Table 
VII. 
 
With our computational method, we can see that 16 out of 
20 predictions with highest probabilities are already 
confirmed with evidence from PubMed ID (PMID). For 
example, CACNA2D1 is proved to be associated with 
stomach cancer and FGGY is known to down regulate in 
stomach cancer tissue in [34] and [35], respectively. Further 
there are four circRNAs are predicted as associated to 
stomach cancer with high probabilities though they are not 
yet confirmed.  
 
 
 
 
TABLE VII.  TOP 20 RESULTS FOR STOMACH CANCER BASED ON PREDICTION SCORE 
Rank circRNA PMID Rank circRNA PMID 
1 CACNA2D1 28618205 11 RHBDD1 29098316 
2 FGGY 28656881 12 TATDN3 28940688 
3 hsa_circ_0000190 28130019 13 VIL1 28639908 
4 hsa_circ_0003159 28618205 14 ASXL1 29109417 
5 hsa_circ_0005529 28737829 15 hsa_circ_0001649 28167847 
6 hsa_circ_0006022 28639908 16 CDR1-AS 28608528 
7 hsa_circ_0032821 28737829 17 hsa_circ_0002113 - 
8 hsa_circ_0085553 28639908 18 circRNA-chr19 - 
9 hsa_circ_0089548 28639908 19 circular_RNA_100783 - 
10 hsa_circ_001066 28184940 20 STAT3 - 
 
IV. CONCLUSION  
In this work, we proposed a novel model which uses 
message passing graph convolutional networks to predict 
circRNA-disease associations. First, our model gets the 
advantage of multiple sources of similarity features such as 
disease and circRNA GIP kernel similarity, circRNA 
sequence similarity to build a meaningful graph structure and 
then graph convolution is utilized to extract high level 
features for each node and finally predict diseases for each 
circRNA. Experiments on different number of disease 
predictions and the performance on individual disease show 
that our model can effectively identify potential associations 
based on previously known associations with over 90% score 
for all the metrices: accuracy, precision, recall, f1 score and 
AUC using 5-fold cross validation. Also, our model has 
competitive performance with 96% AUC compared to other 
existing methods and with the case study we can observe that 
16 out of 20 highest probability predicted circRNA and 
stomach cancer associations are confirmed by published 
literature evidence. Therefore, the proposed computational 
model can provide potential circRNA-disease associativity 
effectively based on rich number of existing associations.  
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